Author Contributions: Dr Kroenke had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Kroenke, Bair, Damush, Sutherland.
Acquisition of data: Kroenke, Bair, Damush, Hoke.
Analysis and interpretation of data: Kroenke, Bair, Damush, Wu, Sutherland, Tu.
Drafting of the manuscript: Kroenke, Wu, Hoke.
Critical revision of the manuscript for important intellectual content: Kroenke, Bair, Damush, Wu, Sutherland, Tu.
Statistical analysis: Kroenke, Wu, Sutherland, Tu.
Obtained funding: Kroenke.
Administrative, technical, or material support: Kroenke, Bair, Damush, Hoke.
Study supervision: Kroenke, Bair, Damush, Hoke.
Financial Disclosures: Dr Kroenke reported receiving research funding from Eli Lilly, Pfizer, and Wyeth, and honoraria as a speaker, consultant, or advisory board member from Eli Lilly, Pfizer, Wyeth, Astra-Zeneca, and Forest Laboratories. Dr Bair reported receiving one-time consultant fees from Wyeth, Abbott, and Cephalon. No other authors reported financial disclosures.
Funding/Support: This study was supported by grant R01 MH-071268 (awarded to Dr Kroenke) from the National Institute of Mental Health.
Role of the Sponsor: The sponsor provided financial support for the study only and had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the study; or in the preparation, review, or approval of the manuscript.
Additional Contributions: We gratefully acknowledge the care management provided by Carol Kempf, RN, and Gloria Nicholas, RN, and the research assistance provided by Monica Huffman, BA. The individuals listed above were compensated as study personnel for these services. We also thank Erin Krebs, MD (Roudebush VA employee; uncompensated for her role in the study) for consultation on the analysis and in the manuscript preparation.